Followers | 6 |
Posts | 1163 |
Boards Moderated | 0 |
Alias Born | 10/25/2016 |
Wednesday, July 05, 2017 4:06:52 PM
http://postanalyst.com/2017/07/03/an-inside-look-at-trading-hot-stocks-avid-technology-inc-avid-arena-pharmaceuticals-inc-arna/
Arena Pharmaceuticals, Inc. (ARNA) Consensus Price Target
The company’s consensus rating on Reuter’s scale slipped from 2.43 to 2.25 during a month. Analysts set a 12-month price target of $35.5 a share. The target implies a 110.43% spike from where the shares are currently trading. Also, the current price highlights a discount of 196.38% to analysts’ high consensus price target.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Intraday Trading
The counter witnessed a trading volume of 0.75 million shares versus an average volume of 0.35 million shares during last trading session. Its last month’s stock price volatility remained 7.44% which for the week approaches 7.22%. The lowest price the stock reached in the last trading day was $15.97 and compares with the $11.3 52-week low. The stock recovered 49.29% since its low point and has performed 18.8% year-to-date.
For direct communication email me futurebankruptcy at gmail dot com
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM